65,437 trials
Pre-diabetes
Primary: Blood Pressure — 116.0; 120.8 mm Hg — p==0.088
Healthy
Primary: Coefficient of Variation (CV) for Gallbladder Ejection Fraction (GBEF) for Each Infusion Method — 51.66; 62.75; 71.38; 40.46 percentage
Non Functioning Entero-pancreatic Endocrine Tumour
Primary: Adverse Events — 40; 46; 86 participants with any TEAEs
Pain · Opiate Addiction
Primary: Total Methadone Peak Plasma Concentration — 107.3; 315.4; 362.2 ng/mL
Stroke
Primary: Self-selected Overground Walking Speed — 0.72; 0.65 meters/s — p=0.72
Spinal Cord Injury
Primary: Ability to Transfer — 32 participants
Colitis, Ulcerative
Primary: Number of Participants Who Achieved Clinical Response Through Maintenance-Week 54 Measured Using the Mayo Score — 6; 18 participants
Oral Hygiene
Primary: Number of Gingival Bleeding Sites at 24 Weeks — 45.13; 45.84; 18.67; 36.39 number of gingival bleeding sites — p=<0.0001
Diabetes Type 2
Primary: Measure of the Mean Night Time Glucose Levels Based on Two Nights of Glucose Measurements. — 13.70; -3.67; 6.64; 1.66 mg/dL — p=0.0117
Vascular Function
Primary: Flow Mediated Dilation, Acute-upon-chronic, Black Tea — 4.24; 4.48; 4.49; 4.87 percentage of flow mediated dilation — p=0.36
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in Glycosylated Haemoglobin (HbA1c) — -1.45; -0.46 percentage of glycosylated haemoglobin — p=< 0.001
Tension-Type Headache
Primary: Number of Subjects Pain Free — 21; 20; 21; 19 Participants
Post-polio Syndrome · Physical Activity · Depression
Primary: PROMIS (Patient Reported Outcomes Measurement Information System) Physical Functioning — 37.8; 37.9; 37.5; 38.1 units on a scale — p=0.66
Myopia
Primary: Comfort — 90; 91; 92; 90 units on a scale
Myopia · Astigmatism
Primary: Overall Comfort — 80; 91; 88 units on a scale